STOCK TITAN

Polyrizon (PLRZ) CFO details initial share and option holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Polyrizon Ltd. Chief Financial Officer BenYosef Nir has filed an initial statement of beneficial ownership, detailing his current equity position in the company. He holds an option to purchase 2 ordinary shares at an exercise price of 1699.3000 per share, expiring on December 26, 2026, alongside direct holdings of ordinary shares.

Footnotes explain that portions of these ordinary shares are restricted and vest over time. One grant vests in 8 equal monthly installments on a quarterly basis beginning on March 30, 2026, while another includes 104 already vested shares and 625 restricted shares vesting in 6 equal quarterly installments beginning on March 31, 2026, all subject to his continued service and structured to qualify for Israeli Section 102 tax benefits through a trustee arrangement.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
BenYosef Nir

(Last)(First)(Middle)
C/O POLYRIZON LTD.
9 HAPNINA STREET

(Street)
RAANANA4321546

(City)(State)(Zip)

ISRAEL

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Polyrizon Ltd. [ PLRZ ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares3(1)D
Ordinary Shares729(2)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Ordinary Shares03/31/202212/26/2026Ordinary Shares2(3)$1,699.3D
Explanation of Responses:
1. These ordinary shares represent restricted ordinary shares, which vest in 8 equal monthly installments on a quarterly basis beginning on March 30, 2026, subject to the Reporting Person's continued service.
2. These ordinary shares represent restricted ordinary shares, of which (1) 104 ordinary shares are vested and (2) 625 restricted ordinary vest in 6 equal quarterly installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service.
3. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Polyrizon Ltd. Amended and Restated Equity Incentive Plan must be registered in the name of a trustee.
/s/ Nir Ben Yosef03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Polyrizon (PLRZ) CFO BenYosef Nir report in this Form 3?

BenYosef Nir reports his initial equity holdings in Polyrizon Ltd., including options and ordinary shares. The filing outlines his option terms, restricted share awards, and vesting schedules tied to continued service and Israeli tax-related plan provisions.

How many Polyrizon (PLRZ) shares can the CFO acquire through options?

The CFO holds an option to purchase 2 Polyrizon ordinary shares at an exercise price of 1699.3000 per share, expiring on December 26, 2026. This option position appears alongside his direct holdings of ordinary shares disclosed in the same Form 3.

How do the restricted Polyrizon (PLRZ) shares held by the CFO vest?

One block of restricted ordinary shares vests in 8 equal monthly installments on a quarterly basis beginning March 30, 2026. Another grant includes 104 already vested shares and 625 restricted shares vesting in 6 equal quarterly installments starting March 31, 2026, contingent on continued service.

What is the significance of Section 102 for Polyrizon (PLRZ) CFO share awards?

To qualify for certain Israeli Section 102 tax benefits, securities issued under Polyrizon’s Amended and Restated Equity Incentive Plan must be registered in a trustee’s name. This structure can improve tax treatment for the employee while maintaining the equity-based compensation framework.

Does this Polyrizon (PLRZ) Form 3 show the CFO buying or selling shares?

The Form 3 functions as an initial ownership report and does not record open-market purchases or sales. It lists existing option and share positions, including restricted stock that will vest over time if the CFO continues his service with Polyrizon.
Polyrizon Ltd

NASDAQ:PLRZ

View PLRZ Stock Overview

PLRZ Rankings

PLRZ Latest News

PLRZ Latest SEC Filings

PLRZ Stock Data

14.06M
1.28M
Biotechnology
Healthcare
Link
Israel
Ra'anana